title: Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia.
authors.affiliation: Division of Hematology, Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA.
authors.forename: M S
authors.initials: MS
authors.lastname: Khodadoust
authors.affiliation: Division of Hematology, Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA.|Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: B
authors.initials: B
authors.lastname: Luo
authors.affiliation: Division of Hematology, Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA.
authors.forename: B C
authors.initials: BC
authors.lastname: Medeiros
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: R C
authors.initials: RC
authors.lastname: Johnson
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: M D
authors.initials: MD
authors.lastname: Ewalt
authors.affiliation: Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: A S
authors.initials: AS
authors.lastname: Schalkwyk
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: C D
authors.initials: CD
authors.lastname: Bangs
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Cherry
authors.affiliation: Division of Bone Marrow Transplantation, Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Arai
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Arber
authors.affiliation: Division of Hematology, Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA.|Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: J L
authors.initials: JL
authors.lastname: Zehnder
authors.affiliation: Division of Hematology, Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA.
authors.forename: J
authors.initials: J
authors.lastname: Gotlib
mesh_terms: D000208:Acute Disease; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015321:Gene Rearrangement; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011379:Prognosis; D011724:Pyridazines / Q000627:therapeutic use*; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D011724:Pyridazines; C545373:ponatinib; C496348:FGFR1 protein, human; D051496:Receptor, Fibroblast Growth Factor, Type 1